Xpansion project : a unique non-clinical facility in Europe

19 July 2022

As part of its growth and international development, Cynbiose is expanding its capacities and preclinical services offer thanks to a unique facility based in France.

This state-of-the-art facility allows us to strengthen our offer, particularly for the evaluation of drug candidates developed to fight infectious and respiratory diseases as well as GMO type products, namely gene therapies and oncolytic viruses.

To find out more about this unique project, find all the information on the origins of this project and the progress of the construction site in images here!

Share this!